SCHEMBL27203397

SCHEMBL27203397

Sc1nc2ccc(Oc3ccccc3)cc2[nH]1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK2 O96017 7/20 0.52
▸ GRIN1 Q05586 6/20 0.52
▸ GRIN2B Q13224 6/20 0.52
▸ CYP1A2 P05177 1/20 0.49
▸ CYP2E1 P05181 1/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ CYP2C8 P10632 1/20 0.49
▸ CYP2D6 P10635 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ CYP2B6 P20813 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ CSNK1A1 P48729 1/20 0.47
▸ CSNK1D P48730 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ TP53 P04637 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ NFKB1 P19838 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25931657 0.81 CHEK2 (0.59) CHEK2GRIN1GRIN2BCYP1A2CYP2E1
SCHEMBL12909164 0.81 ALDH1A1 (0.63) CHEK2GRIN1GRIN2BCYP1A2CYP2E1
SCHEMBL7808795 0.80 GRIN1 (0.62) CHEK2GRIN1GRIN2BCYP1A2CYP2E1
SCHEMBL4825999 0.79 CYP3A4 (0.54) CHEK2CYP1A2CYP2E1CYP3A4CYP2C8
SCHEMBL26189984 0.78 NPC1 (0.40) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL916533 0.78 NPC1 (0.58) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL29770426 0.78 NPC1 (0.58) CYP1A2CYP2E1CYP3A4CYP2C8CYP2D6
SCHEMBL11191139 0.78 MAOB (0.46) CHEK2GRIN1GRIN2BKDM4ENPC1
SCHEMBL24953738 0.77 KDM4E (0.60) CHEK2GRIN1GRIN2BCYP1A2CYP2E1
SCHEMBL7807073 0.77 GRIN1 (0.62) CHEK2GRIN1GRIN2BCYP1A2CYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240132479-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2024-04-25 — — US disclosed
WO-2022165198-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2022-08-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240132479-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF CUTA, DCXR, PLOD3 CHEK2 3840/4885GRIN1 4482/4885GRIN2B 4451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback